The global problem of antifungal resistance: prevalence, mechanisms, and management

DS Perlin, R Rautemaa-Richardson… - The Lancet infectious …, 2017 - thelancet.com
All serious fungal infections need appropriate antifungal therapy for successful patient outcome.
Only a few classes of antifungal drugs are available, so the emergence of resistance to …

Global burden of recurrent vulvovaginal candidiasis: a systematic review

…, JD Sobel, R Rautemaa-Richardson - The Lancet infectious …, 2018 - thelancet.com
Recurrent vulvovaginal candidiasis is a debilitating, long-term condition that can severely
affect the quality of life of affected women. No estimates of the global prevalence or lifetime …

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I

…, J Perheentupa, R Rautemaa… - Journal of internal …, 2009 - Wiley Online Library
Autoimmune polyendocrine syndrome type I (APS‐I) is a monogenic model disease of
autoimmunity. Its hallmarks are chronic mucocutaneous candidosis, hypoparathyroidism and …

[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …

…, M Bassetti, S Hatzl, R Rautemaa-Richardson… - Clinical Microbiology …, 2022 - Elsevier
Objectives Coronavirus disease 2019 (COVID-19) -associated pulmonary aspergillosis (CAPA)
has emerged as a complication in critically ill COVID-19 patients. The objectives of this …

[HTML][HTML] Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris

…, MD Richardson, R Rautemaa-Richardson - Emerging infectious …, 2017 - ncbi.nlm.nih.gov
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable
attention as a source of healthcare–associated infections. We report that this highly virulent …

Bacterial aerosols in dental practice–a potential hospital infection problem?

R Rautemaa, A Nordberg, K Wuolijoki-Saaristo… - Journal of hospital …, 2006 - Elsevier
Aerosols containing microbes from the oral cavity of the patient are created when using
modern high-speed rotating instruments in restorative dentistry. How far these aerosols spread …

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

…, CB Moore, R Rajendran, R Rautemaa… - Journal of …, 2013 - academic.oup.com
Objectives Recent increases in triazole resistance in Aspergillus fumigatus have been
attributed primarily to target site (cyp51A) mutations. A recent survey of resistant isolates in …

Oral candidosis–clinical challenges of a biofilm disease

R Rautemaa, G Ramage - Critical reviews in microbiology, 2011 - Taylor & Francis
This review summarizes the impact of biofilms in oral candidosis with special emphasis on
medically compromised patients. The concept of oral candidosis as a mixed candidal-…

[HTML][HTML] Oral infections and systemic disease—an emerging problem in medicine

R Rautemaa, A Lauhio, MP Cullinan… - Clinical Microbiology and …, 2007 - Elsevier
The relationship between oral and general health has been increasingly recognised during
the past two decades. Several epidemiological studies have linked poor oral health with …

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

…, T Papp, R Rautemaa-Richardson… - The Lancet Infectious …, 2021 - thelancet.com
Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients
who are immunocompromised or seriously ill. The major pathogens include those of the …